Fondaparinux to Prevent Thrombotic Complications & Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery.
To demonstrate the feasibility of recruiting patients into this study and of performing CT angiograms to measure graft patency at 30 days. Our pilot study will provide key information about feasibility that will help us to design and perform a large definitive study in the future.
Randomized, treatment, open label, active control, parallel group design.
All primary and secondary endpoints are adjudicated. Graft patency. Secondary Endpoint: Myocardial infarction, Stroke, Death, Bleeding events, Transfusion requirements, Re-operation.